MedTrace Logo

Oral Antibiotics After Obstetric Perineal Tear

NCT05830162 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 442

Last updated 2024-12-12

No results posted yet for this study

Summary

The purpose of this study is to investigate if 3 dose of oral antibiotics administrated the first day after a vaginal delivery with a second degree obstetric tear will decrease the risk of infection and/or wound dehiscence compared to women with 3 doses of placebo treatment.

Conditions

Interventions

DRUG

Placebo

We will evaluate how many women gets an infection and/or wound dehiscence after a second degree obstetric tear or episiotomy

DRUG

Bioclavid (Amoxicillin and Clavulanic acid)

We will evaluate how many women gets an infection and/or wound dehiscence after a second degree obstetric tear or episiotomy

Sponsors & Collaborators

  • Region Hovedstadens Apotek

    collaborator OTHER_GOV

  • Hanna Jangö

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-21
Primary Completion
2024-01-04
Completion
2024-12-09

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05830162 on ClinicalTrials.gov